Elke Reiβmüller

Title: The Innovative Contributions of Elke Reiβmüller

Introduction

Elke Reiβmüller is a notable inventor based in Wuppertal, Germany. She has made significant contributions to the field of pharmaceuticals, particularly through her innovative work on tetrahydro-quinolinylurea derivatives. Her research focuses on developing active ingredients that can be utilized in various pharmaceutical preparations.

Latest Patents

Elke Reiβmüller holds 1 patent for her invention related to tetrahydro-quinolinylurea derivatives and their salts. This invention is particularly valuable due to its vanilloid receptor (VR1) antagonistic activity. It has potential applications in the prophylaxis and treatment of several diseases associated with VR1 activity. These include urological disorders such as overactive bladder, urinary incontinence, and benign prostatic hyperplasia, as well as chronic pain conditions and inflammatory disorders like asthma and chronic obstructive pulmonary disease (COPD).

Career Highlights

Elke Reiβmüller is currently associated with Bayer Schering Pharma AG, where she continues to advance her research and development efforts. Her work has been instrumental in creating new therapeutic options for patients suffering from various medical conditions.

Collaborations

Elke collaborates with Nicole Diedrichs, who is also a key figure in her research endeavors. Their partnership enhances the innovative potential of their projects and contributes to the advancement of pharmaceutical science.

Conclusion

Elke Reiβmüller exemplifies the spirit of innovation in the pharmaceutical industry through her groundbreaking work on tetrahydro-quinolinylurea derivatives. Her contributions are paving the way for new treatments that can significantly improve patient outcomes.